ilkinson等~1在最近的论文中论证了给予异烟肼(H),利福平(R),吡嗪酰胺(Z)和链霉素(S)四种药周二次在直接观察下治疗6个月,可不必了解既往治疗史,也不需获得强化期治疗结束时的痰涂片检查结果,他们的论据是在他们的研究中发现该资料对预测以后的失败或复发几乎不起作用。由于掌握既往史和强化期结束时痰检查情况是国际防痨和肺病联合会(IUATLD)和世界卫生组织(WHO)对结核病控制规程所推荐的重要策略的组成部分~2。在放弃它之前对它们的合理性进行讨论是恰当的,因为它们在七十 In a recent paper, ilkinson et al.1 demonstrated that twice weekly administration of isoniazid (H), rifampin (R), pyrazinamide (Z), and streptomycin (S) Months, you do not have to know the history of previous treatment, and did not need to get sputum smear results at the end of intensive treatment, their argument is that in their study found that the data to predict the failure or recurrence of almost no effect. Because mastery of past history and sputum examination at the end of intensive phase is part of an important strategy recommended by the IUATLD and the WHO for tuberculosis control protocols. It is appropriate to discuss their rationality before giving it up because they are seventy